NCT07477548 2026-03-17
A Study to Evaluate the Efficacy and Safety of Everolimus in Patients With Teratment-refractory Vascular Anomalies
Yonsei University
Phase 2 Not yet recruiting
Clinical Trials
12 trialsNCT02913612 2024-03-12
TIM01
Duke University
Phase 2 Completed
NCT04684667 2020-12-24
''Efficacy of Propranolol in the Treatment of Infantile Hemangioma"
Assiut University
Phase 2 Unknown
NCT02731287 2018-11-14
Topical Timolol for Infantile Hemangioma in Early Proliferative Phase
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Phase 2 Completed
NCT01074437 2018-10-04
Corticosteroids With Placebo Versus Corticosteroids With Propranolol Treatment of Infantile Hemangiomas (IH)
Seattle Children's Hospital
Phase 2 Terminated
NCT02145884 2017-02-13
Topical Timolol Gel for the Treatment of Infantile Hemangiomas
Rady Children's Hospital, San Diego
Phase 2 Completed
NCT00967226 2016-02-24
Propranolol Versus Prednisolone for Treatment of Symptomatic Hemangiomas
Children's National Research Institute
Phase 2 Terminated
NCT01072045 2014-12-02
Comparative Study of the Use of Beta Blocker and Oral Corticosteroid in the Treatment of Infantile Hemangioma
University of Sao Paulo
Phase 2 Completed
NCT01512173 2014-10-30
Study in Infants With Infantile Hemangioma to Compare Propranolol Gel to Placebo
Pierre Fabre Dermatology
Phase 2 Completed
NCT01408056 2014-01-17
TOUCH
Children's Hospital of Philadelphia
Phase 2 Withdrawn
NCT00555464 2013-06-11
Clinical Trial of Vincristine vs. Prednisolone for Treatment of Complicated Hemangiomas
Medical College of Wisconsin
Phase 2 Terminated
NCT00601016 2008-01-25
A Phase II Study of Imiquimod 5 % Cream for the Treatment of Hemangioma in Infancy
St. Justine's Hospital
Phase 2 Completed